Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (Q44113847)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2002
edit
Language Label Description Also known as
English
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
scientific article published in September 2002

    Statements

    Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (English)
    Lars H Lindholm
    Hans Ibsen
    Knut Borch-Johnsen
    Michael Hecht Olsen
    Kristian Wachtell
    Gareth Beevers
    Frej Fyhrquist
    Stevo Julius
    Krister Kristianson
    Markku S Nieminen
    Per Omvik
    Hans Wedel
    Peter Aurup
    Jonathan M Edelman
    Steven Snapinn
    LIFE study group
    1 September 2002
    1879-1886

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit